During the first session, MPs heard from witnesses about the concerns over the future of chemical regulations, whilst the second session focussed on issues that could arise from the UK leaving the EU, including concerns over supply chain disruption. Nishma Patel of the Chemical Industries Association said the EU REACH programme (Registration, Evaluation, Authorisation & restriction of Chemicals) had helped provide more information for companies, including for those further down the supply chain. Mike Murray, Head of Quality and Environmental Standards, The Association of the British Pharmaceutical Industry, said that a transitional period would be required to ensure that there was no disruption to the supply chain. He added that it made a big impact on a business whether it was a member of REACH or not, but had little impact on patients.
Other contributors included Dr Camilla Alexander-White, Douglas Leech and Susanne Baker who all spoke about their concerns over how long it would take the UK to build its own regulatory framework outside of the EU as well as supply chain risks.